Abridge

Enterprise Systems (Healthcare)Website
Current Valuation
$5.3B
As of June 24, 2025
Total Funding Raised
$779.8M
Across 3 rounds
Last Round
Later Stage VC

$315.9M

Last Funding
Jun 2025

Funding date

Capital Efficiency
6.80x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
February 17, 2025Later Stage VC (Series D)$250.0MN/A-
February 22, 2024Later Stage VC (Series C)$150.0MN/A-
October 20, 2023Later Stage VC (Series B)$30.0MN/A-
Valuation Analysis

Current Valuation Metrics

Abridge is currently valued at $5.3B as of June 24, 2025. The company has raised a total of $779.8M in funding across 3 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 6.80x, Abridge has achieved a valuation that is 6.80 times the total capital raised.

Track Abridge Valuation Updates

Get notified when Abridge raises new funding or valuation changes

View 5 companies free

Create a free account to unlock Abridge's valuation history, funding rounds, and growth metrics.

No credit card required

What is Abridge Worth in 2026?

Abridge is a leading private company in the Enterprise Systems (Healthcare) sector. Track Abridge's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Abridge Valuation is Determined

Private company valuations like Abridge's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.